8622 — Huakang Biomedical Holdings Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$180.17m
- HK$142.57m
- CNY25.36m
Annual cashflow statement for Huakang Biomedical Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -11.4 | -3.9 | -3.01 | -5.78 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 5.9 | 0.433 | 0.057 | 1.62 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.65 | -1.86 | 1.1 | 0.939 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.92 | -2.38 | 1.29 | -0.048 | — |
| Capital Expenditures | -2.08 | -2.33 | -0.811 | -1.5 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.145 | 0.276 | -5.3 | 0.349 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.94 | -2.06 | -6.11 | -1.15 | — |
| Financing Cash Flow Items | — | 0.101 | 1.31 | 1.44 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.11 | -1.37 | 2.32 | 1.02 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.85 | -5.74 | -2.9 | -0.368 | — |